Baader Bank Aktiengesellschaft Has $504,000 Holdings in Tilray Inc (NASDAQ:TLRY)

Baader Bank Aktiengesellschaft lifted its holdings in Tilray Inc (NASDAQ:TLRY) by 103.1% during the 2nd quarter, Holdings Channel reports. The fund owned 304,582 shares of the company’s stock after acquiring an additional 154,582 shares during the quarter. Baader Bank Aktiengesellschaft’s holdings in Tilray were worth $504,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also modified their holdings of the business. Prospect Financial Services LLC bought a new position in Tilray in the 2nd quarter worth approximately $26,000. Gainplan LLC bought a new position in Tilray in the 4th quarter worth approximately $28,000. Simplicity Wealth LLC bought a new position in Tilray in the 1st quarter worth approximately $28,000. RPO LLC bought a new position in Tilray in the 4th quarter worth approximately $28,000. Finally, Wellington Wealth Strategies LLC. bought a new stake in shares of Tilray during the 4th quarter valued at $29,000. 9.35% of the stock is owned by institutional investors and hedge funds.

Tilray Stock Up 1.6 %

Shares of Tilray stock traded up $0.03 during trading hours on Thursday, reaching $1.95. 19,436,513 shares of the company’s stock were exchanged, compared to its average volume of 25,872,123. The company has a 50 day moving average of $1.79 and a two-hundred day moving average of $1.88. Tilray Inc has a fifty-two week low of $1.50 and a fifty-two week high of $3.40. The company has a current ratio of 2.27, a quick ratio of 1.42 and a debt-to-equity ratio of 0.10. The stock has a market cap of $1.64 billion, a P/E ratio of -4.49 and a beta of 2.19.

Tilray (NASDAQ:TLRY) last posted its quarterly earnings data on Monday, July 29th. The company reported ($0.04) EPS for the quarter, missing analysts’ consensus estimates of ($0.02) by ($0.02). Tilray had a negative return on equity of 2.63% and a negative net margin of 30.26%. The business had revenue of $229.90 million for the quarter, compared to analyst estimates of $226.20 million. During the same quarter in the prior year, the company earned ($0.15) earnings per share. The company’s quarterly revenue was up 24.8% on a year-over-year basis. On average, sell-side analysts forecast that Tilray Inc will post -0.12 EPS for the current fiscal year.

Tilray Profile

Tilray, Inc engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc is headquartered in Nanaimo, Canada.